We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+5.76%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$24.1B
AUM Growth
+$1.31B
(+5.8%)
Cap. Flow
+$207M
Cap. Flow
% of AUM
0.86%
Top 10 Holdings %
Top 10 Hldgs %
6.52%
Holding
2,393
New
154
Increased
1,057
Reduced
989
Closed
188
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$53.3M |
| 2 |
Philip Morris
PM
|
+$50.2M |
| 3 |
Brown-Forman Class B
BF.B
|
+$46.9M |
| 4 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
+$45.5M |
| 5 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$45.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enterprise Products Partners
EPD
|
+$142M |
| 2 |
EEP
Enbridge Energy Partners
EEP
|
+$94.6M |
| 3 |
Merck
MRK
|
+$70M |
| 4 |
KMR
KINDER MORGAN MANAGEMENT LLC
KMR
|
+$68.7M |
| 5 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$56.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.85% |
| 2 | Technology | 12.34% |
| 3 | Industrials | 9.86% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Energy | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Akamai
AKAM
$16.8B
| $88.8M | 0.37% |
1,453,670
+57,002
| +4% | +$3.17M |
|
27
Microsoft
MSFT
$2.84T
| $86.6M | 0.36% |
2,076,080
+446,032
| +27% | +$18.1M |
|
|
GMCR
28
DELISTED
KEURIG GREEN MTN INC
GMCR
| $85.6M | 0.36% |
687,162
+417,351
| +155% | +$45.5M |
|
29
TripAdvisor
TRIP
$1.59B
| $83.8M | 0.35% |
771,590
-120,563
| -14% | -$11.1M |
|
30
Molson Coors Class B
TAP
$7.68B
| $83.5M | 0.35% |
1,125,765
+267,971
| +31% | +$17.3M |
|
31
Regeneron Pharmaceuticals
REGN
$68.8B
| $79.8M | 0.33% |
282,454
+25,981
| +10% | +$7.7M |
|
|
CELG
32
DELISTED
Celgene Corp
CELG
| $79.6M | 0.33% |
926,797
-426,207
| -32% | -$32.4M |
|
33
Amgen
AMGN
$203B
| $78.9M | 0.33% |
666,495
+56,724
| +9% | +$6.57M |
|
34
Eli Lilly
LLY
$1.07T
| $77.8M | 0.32% |
1,251,493
-321,066
| -20% | -$19.2M |
|
|
WBA
35
DELISTED
Walgreens Boots Alliance
WBA
| $77.1M | 0.32% |
1,040,046
+387,102
| +59% | +$27M |
|
|
WWAV
36
DELISTED
The WhiteWave Foods Company
WWAV
| $77M | 0.32% |
2,377,387
+416,886
| +21% | +$12.5M |
|
|
EXAS
37
DELISTED
Exact Sciences
EXAS
| $76.5M | 0.32% |
4,491,304
+428,795
| +11% | +$5.9M |
|
|
DF
38
DELISTED
Dean Foods Company
DF
| $75.3M | 0.31% |
4,278,304
+1,730,273
| +68% | +$28.3M |
|
|
JNPR
39
DELISTED
Juniper Networks
JNPR
| $74.1M | 0.31% |
3,018,652
-338,200
| -10% | -$8.4M |
|
40
Ingredion
INGR
$6.38B
| $72.9M | 0.3% |
971,608
+324,874
| +50% | +$23.6M |
|
41
Bio-Techne
TECH
$11.2B
| $72.7M | 0.3% |
3,142,052
-44,668
| -1% | -$987K |
|
|
42
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.8B
| $72.2M | 0.3% |
876,359
+591,216
| +207% | +$45.2M |
|
43
United Therapeutics
UTHR
$26.3B
| $71.1M | 0.3% |
803,017
-133,867
| -14% | -$12.9M |
|
|
SWY
44
DELISTED
SAFEWAY INC
SWY
| $70.4M | 0.29% |
2,048,788
+813,698
| +66% | +$27.8M |
|
45
Constellation Brands
STZ
$22.2B
| $70.2M | 0.29% |
797,064
+147,608
| +23% | +$12.2M |
|
46
Equinix
EQIX
$107B
| $69.3M | 0.29% |
329,849
-88,679
| -21% | -$17.1M |
|
|
QGENF
47
DELISTED
QIAGEN NV
QGENF
| $68.6M | 0.29% |
2,806,244
+401,313
| +17% | +$9.81M |
|
48
Nektar Therapeutics
NKTR
$2.39B
| $67.4M | 0.28% |
350,451
+53,120
| +18% | +$9.39M |
|
49
First Trust Health Care AlphaDEX Fund
FXH
$1.02B
| $67M | 0.28% |
1,257,813
+848,404
| +207% | +$43.1M |
|
50
First Trust Dow Jones Internet Index Fund ETF
FDN
$4.86B
| $65.8M | 0.27% |
1,103,806
+744,670
| +207% | +$42.1M |
|
Similar funds
DAM
First Trust Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, First Trust Advisors held 2,393 positions worth $24.1B, up 5.8% from $22.8B the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.
First Trust Advisors's Q2 2014 filing shows 154 new, 1,057 increased, 989 reduced and 188 closed positions. Its largest new stake was Brookdale Senior Living: 1,010,257 shares worth $33.7M. The largest sale was Enterprise Products Partners, an estimated $142M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.
- First Trust Advisors's largest Q2 2014 buy was Brookdale Senior Living: 1,010,257 shares worth $33.7M.
- First Trust Advisors added most to Pfizer in Q2 2014, an estimated $53.3M increase.
- First Trust Advisors's biggest Q2 2014 reduction was Enterprise Products Partners, cutting an estimated $142M.
- First Trust Advisors fully exited KINDER MORGAN MANAGEMENT LLC in Q2 2014, selling an estimated $68.7M.
- First Trust Advisors's ten largest holdings make up 6.5% of its $24.1B portfolio in Q2 2014.
- First Trust Advisors opened 154 new positions and closed 188 in Q2 2014.
- First Trust Advisors's portfolio value rose 5.8% quarter-over-quarter to $24.1B.
Based on First Trust Advisors's 13F filing for Q2 2014, filed 11 Aug 2014.